PROM Clinical Trials

70 recruitingLast updated: June 18, 2026

There are 70 actively recruiting prom clinical trials across 34 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4. Top locations include Houston, Texas, United States, New York, New York, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


PROM Trials at a Glance

70 actively recruiting trials for prom are listed on ClinicalTrialsFinder across 6 cities in 34 countries. The largest study group is Not Applicable with 25 trials, with the heaviest enrollment activity in Houston, New York, and Boston. Lead sponsors running prom studies include M.D. Anderson Cancer Center, Fondazione IRCCS Policlinico San Matteo di Pavia, and Assistance Publique - Hôpitaux de Paris.

Browse prom trials by phase

Treatments under study

About PROM Clinical Trials

Looking for clinical trials for PROM? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new PROM trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about PROM clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 70 trials

Recruiting
Not Applicable

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

Skin CancerSquamous Cell CarcinomaBrachytherapy+3 more
Alpha Tau Medical LTD.28 enrolled11 locationsNCT06615635
Recruiting
Phase 1

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

SarcomaPrecursor Cell Lymphoblastic Leukemia-LymphomaNeurofibroma, Plexiform+1 more
National Cancer Institute (NCI)54 enrolled1 locationNCT02390752
Recruiting
Phase 3

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Acute promyelocytic leukaemiaAcute Promyelocytic LeukemiaAcute Promyelocytic Leukemia With PML-RARA+2 more
Quetzal Therapeutics150 enrolled7 locationsNCT07504458
Recruiting
Not Applicable

FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized Communities

Digital health literacyIron-Deficiency AnemiaHealth Promotion Model (HPM)
Cairo University160 enrolled1 locationNCT07633262
Recruiting
Not Applicable

Digital Engagement for Lifelong Health

Health PromotionRisk ReductionLife Style, Healthy
Istituto per la Ricerca e l'Innovazione Biomedica200 enrolled1 locationNCT07612852
Recruiting
Phase 2

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center151 enrolled5 locationsNCT01409161
Recruiting
Phase 3

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

COVID-19Lower Respiratory Tract InfectionImmunocompromised+1 more
Ansun Biopharma, Inc.274 enrolled67 locationsNCT03808922
Recruiting
Not Applicable

Danish Vulva Cancer Recurrence Study

SurvivorshipCirculating Tumor DNAVulvar Cancer+6 more
University of Aarhus1,295 enrolled2 locationsNCT06495554
Recruiting
Not Applicable

ePlatform for Promoting Health in Schools

Health PromotionHealth EducationPhysical Activity+2 more
Fundació Sant Joan de Déu1,000 enrolled1 locationNCT06792461
Recruiting

Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

PneumocystisImmunocompromised Patients
Assistance Publique - Hôpitaux de Paris240 enrolled4 locationsNCT06890078
Recruiting

Pediatric Anesthesia: The Childs Voice

PROMsPediatric AnesthesiaPREMs+1 more
Gødstrup Hospital250 enrolled3 locationsNCT07289152
Recruiting
Not Applicable

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

Telemedicine-Based EducationResilience,PsychologicalPatient-Reported Outcome Measures (PROMs)+3 more
Carelon Research390 enrolled14 locationsNCT07525843
Recruiting
Not Applicable

Social Prescribing Intervention for Health Promotion in Community-Dwelling Older Adults

Health PromotionAgingMental Health
National Health Research Institutes, Taiwan1,500 enrolled1 locationNCT07540117
Recruiting
Phase 1

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid LeukemiaAcute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center77 enrolled1 locationNCT02390635
Recruiting
Not Applicable

Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement

Temporomandibular Disorders (TMD)Internal Derangement of the Tempromandibular JointAnterior Disc Displacement
Horus University32 enrolled1 locationNCT07075276
Recruiting
Phase 2

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

COVID-19Inflammatory Bowel DiseaseRheumatoid Arthritis (RA)+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre660 enrolled3 locationsNCT06599658
Recruiting

Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients

Immunocompromised Patients
Fondazione IRCCS Policlinico San Matteo di Pavia300 enrolled1 locationNCT07321808
Recruiting
Not Applicable

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

Health PromotionOpioid-use DisorderHarm Reduction
University of Pennsylvania390 enrolled3 locationsNCT06843213
Recruiting
Phase 1

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Hematopoietic and Lymphoid Cell NeoplasmImmunocompromised
M.D. Anderson Cancer Center16 enrolled1 locationNCT03425526
Recruiting

6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks

Children Born to Mothers Enrolled in the TOCOPROM Trial
Assistance Publique - Hôpitaux de Paris480 enrolled1 locationNCT07146451